|

Nanoliposomal Irinotecan Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ONIVYDE, Onivyde

Pipeline

Phase 2: 2

Top Sponsors

  • Tiago Biachi de Castria1
  • AstraZeneca1

Indications

  • Cancer2
  • Small Bowel Adenocarcinoma1
  • Pancreatic Ductal Adenocarcinoma1
  • Biliary Tract Cancer1
  • Gastric Cancer1

Orange, California1 trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site

Phase 2

Tampa, Florida1 trial

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.